ARGX argenx SE ADRs

argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:ARGX.

$374.17  +9.82 (2.70%)
As of 06/27/2022 15:59:54 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  05/18/2017
Outstanding shares:  53,619,013
Average volume:  318,838
Market cap:   $19,546,811,189
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BDVLM39

---

Valuation   (See tab for details)

---

PE ratio:   -60.73
PB ratio:   7.43
PS ratio:   38.69
Return on equity:   -10.90%
Net income %:   -63.66%